Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention

European Journal of Internal Medicine

Volumn 19, Issue 6, 2008, Pages 435-442

  Brunetti, Natale Daniele ^a   Quagliara, Donato ^b   Di Biase, Matteo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Coronary angioplasty; Risk stratification; Troponin

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; Q WAVE; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TROPONIN I;

EID: 51449114086     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.04.027     Document Type: Article

References (60)

1. Klein L.W., Kramer B.L., Howard E., and Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol 17 (1991) 621-626
2. Califf R.M., Abdelmeguid A.E., Kuntz R.E., Popma J.J., Davidson C.J., Cohen E.A., et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 31 2 (1998) 241-251
3. Harrington R.A. Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation, and mortality. J Am Coll Cardiol 35 (2000) 1142-1144
4. Holmes Jr. D.R., and Berger P.B. Troponisms, necrosettes, enzyme leaks, creatine phosphokinase bumps, and infarclets: what's behind this new lexicon and what does it add?. Circulation 104 (2001) 627-629
5. Baim D.S., Cutlip D.E., Sharma S.K., Ho K.K., Fortuna R., Schreiber T.L., et al. Results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation 97 (1998) 322-331
6. Oh J.K., Shub C., Ilstrup D.M., and Reeder G.S. Creatine kinase release after successful percutaneous transluminal coronary angioplasty. Am Heart J 109 (1985) 1225-1231
7. Kugelmass A.D., Cohen C.J., Moscucci M., Piana R.N., Senerchia C., Kuntz R.E., et al. Elevation of creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 74 (1994) 748-754
8. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., and Bonow R.O. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 277 (1997) 461-466
9. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., and Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 94 (1996) 1528-1536
10. Abdelmeguid A.E., Whitlow P.L., Sapp S.K., Ellis S.G., and Topol E.J. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation 91 (1995) 2733-2741
11. Abdelmeguid A.E., Ellis S.G., Sapp S.K., Whitlow P.L., and Topol E.J. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J 131 (1996) 1097-1105
12. Redwood S.R., Popma J.J., Kent K.M., Pichard A.D., Satler L.F., Mintz G.S., et al. Predictors of late mortality following ablative new device angioplasty in native coronary arteries [abstract]. J Am Coll Cardiol 27Suppl A (1996) 167A-168A
13. Tardiff B.E., Califf R.M., Tcheng J.E., Lincoff A.M., Sigmon K.N., Harrington R.A., et al. for the IMPACT II Investigators Post-intervention cardiac enzyme elevations: prognostic significance in IMPACT-II [abstract]. J Am Coll Cardiol 27Suppl A (1996) 83A
14. Topol E.J., Ferguson J.J., Weisman H.F., Tcheng J.E., Ellis S.G., Kleiman N.S., et al. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention: EPIC Investigator Group: Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. JAMA 278 (1997) 479-484
15. Ohman E.M., and Tardiff B.E. Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization: importance and implications. JAMA 277 (1997) 495-497
16. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., and Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 104 (2001) 642-647
17. Ellis S.G., Chew D., Chan A., Whitlow P.L., Schneider J.P., and Topol E.J. Death following creatine kinase-MB elevation after coronary intervention. Circulation 106 (2002) 1205-1210
18. Adams III J.E., Bodor G.S., Davila-Roman V.G., Delmez J.A., Apple F.S., Ladenson J.H., et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88 (1993) 101-106
19. Bertinchant J.P., Larue C., Pernel I., Ledermann B., Fabbro-Peray P., Beck L., et al. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem 29 (1996) 587-594
20. Mair J., Genser N., Morandell D., Maier P., Lechleitner P., Calzolari C., et al. Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta 245 (1996) 19-38
21. Larue C., Calzolari C., Bertinchant J.P., Leclercq F., Grolleau R., and Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 39 (1993) 972-979
22. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335 (1996) 1342-1349
23. Adams III J.E., Sicard G.A., Allen B.T., Bridwell K.H., Lenke L.G., Davila-Roman V.G., et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 330 (1994) 670-674
24. Adams J.E., Davila-Roman V.G., Bessey P.Q., Blake D.P., Ladenson J.H., and Jaffe A.S. Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 131 (1996) 308-312
25. Karim M.A., Shinn M., Oskarsson H., Windle J., and Deligonul U. Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol 76 (1995) 521-523
26. Abbas S.A., Glazier J.J., Wu A.H.B., Dupont C., Green S.F., Pearsall L.A., et al. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol 19 (1996) 782-786
27. Kizer J.R., Muttrej M.R., Matthai W.H., McConnell J., Nardone H., Sonel A.F., et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 24 (2003) 1314-1322
28. Garbaz E., Iung B., Lefevre G., Makita Y., Farah B., Michaud P., et al. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 84 (1999) 515-518
29. Baim D.S., Cutlip D.E., Sharma S.K., Ho K.K.L., Fortuna R., Schreiber T.L., et al. For the BOAT Investigators Final Results of the Balloon vs Optimal Atherectomy Trial (BOAT). Circulation 97 (1998) 322-331
30. Harrington R.A., Lincoff A.M., Califf R.M., Holmes Jr. D.R., Berdan L.G., O'Hanesian M.A., et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll Cardiol 25 (1995) 1693-1699
31. Elliott J.M., Berdan L.G., Holmes D.R., Isner J.M., King S.B., Keeler G.P., et al. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I). Circulation 91 (1995) 2158-2166
32. Cavallini C., Savonitto S., Violini R., Arraiz G., Plebani M., Olivari Z., et al. On behalf of the Italian 'Atherosclerosis, Thrombosis, and Vascular Biology' and 'Society for Invasive Cardiology-GISE' Investigators. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J 26 (2005) 1494-1498
33. Ioannidis J.P., Karvouni E., and Katritsis D.G. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 42 8 (Oct 15 2003) 1406-1411
34. Prasad A., Singh M., Lerman A., Lennon R.J., Holmes D.R., and Rihal C.S. Isolated elevation in Troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol 48 (2006) 1765-1770
35. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
36. Genser N., Mair J., Talasz H., Puschendorf B., Calzolari C., Larue C., et al. Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury. Clin Chim Acta 265 (1997) 207-217
37. Liu M.W., Douglas Jr. J.S., Lembo N.J., and King III S.B. Angiographic predictors of a rise in serum creatine kinase (distal embolization) after balloon angioplasty of saphenous vein coronary artery bypass grafts. Am J Cardiol 72 (1993) 514-517
38. Kanaparti P.K., and Brown D.L. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention. Am J Cardiol 86 (2000) 619-622
39. Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Satler L.F., et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions intravascular ultrasound study of 2256 patients. Circulation 101 (2000) 604-610
40. Narins C.R., Hillegass Jr. W.B., Nelson C.L., Tcheng J.E., Harrington R.A., Phillips H.R., et al. Relation between activated clotting time during angioplasty and abrupt closure. Circulation 93 (1996) 667-671
41. Gurbel P.A., Navetta F.I., Bates E.R., Muller D.W., Tenaglia A.N., Miller M.J., et al. Lesion-directed administration of tissue-plasminogen activator with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Catheter Cardiovasc Diagn 36 (1995) 377-380
42. Costa M.A., Carere R., Lichtenstein S.V., Foley D.P., de Valk V., Lindenboom W., et al. On behalf of ARTS study group. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS). Circulation 104 (2001) 2689-2693
43. Heyndrickx G.R., Amano J., Kenna T., Fallon J.T., Patrick T.A., Manders T., et al. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 6 (1985) 1299-1303
44. Selvanayagam J.B., Porto I., Channon K., Petersen S.E., Francis J.M., Neubauer S., et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury. Circulation 111 (2005) 1027-1032
45. Pauletto P., Piccolo D., Scannapieco G., Vescovo G., Zaninotto M., Corbara F., et al. Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris. Am J Cardiol 59 (1987) 999-1000
46. Dillon M.C., Calbreath D.F., Dixon A.M., Rivin B.E., Roark S.F., Ideker R.E., et al. Diagnostic problems in acute myocardial infarction: CK-MB in the absence of abnormally elevated total creatine kinase levels. Arch Intern Med 142 (1982) 33-38
47. Jacobey J.A., Taylor W.J., Smith G.T., Gorlin R., and Harken D.E. A new therapeutic approach to coronary artery occlusion. Am J Cardiol 9 (1962) 60-73
48. Euler D.E., Prood C.E., Spear J.F., and Moore E.N. The interruption of collateral blood flow to the ischemic myocardium by embolization of a coronary artery with latex: effects on conduction delay and ventricular arrhythmias. Circ Res 49 (1981) 97-108
49. Fuessl R.T., Mintz G.S., Pichard A.D., Kent K.M., Satler L.F., Popma J.J., et al. In vivo validation of intravascular ultrasound length measurements using a motorized transducer pullback device. Am J Cardiol 77 (1996) 1115-1118
50. Marcus E., Katz L.N., Pick R., and Stamler J. The production of myocardial infarction, chronic coronary insufficiency and chronic heart disease in the dog. Acta Cardiol 13 (1958) 190-198
51. Miller W.L., Garratt K.N., Burritt M.F., Lennon R.J., Reeder G.S., and Jaffe A.S. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J 27 (2006) 1061-1069
52. Ellis S.G., Lincoff A.M., Whitlow P.L., Raymond R.E., Franco I., Schneider J.P., et al. Evidence that angiotensinconverting enzyme inhibitor use diminishes coronary revascularization after stenting. Am J Cardiol 89 (2002) 937-940
53. Briguoria C., Colombo A., Airoldi F., Violante A., Focaccio A., Balestrieri P., et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J 25 (2004) 1822-1828
54. Pasceri V., Patti G., Nusca A., Pristipino C., Richichi G., and Di Sciascio G. On behalf of the ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 110 6 (Aug 10 2004) 674-678 Electronic publication 2004 Jul 26
55. Desmet W.J.R., Dens J., Coussement P., and Van de Werf F. Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. Heart 88 (2002) 293-295
56. Wang F.W., Osman A., Otero J., Stouffer G.A., Waxman S., Afzal A., et al. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation 107 (2003) 2914-2919
57. Sharma S.K., Kini A., Marmur J.D., and Fuster V. Cardioprotective effect of prior b-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention benefit is extended to improvement in intermediate-term survival. Circulation 102 (2000) 166-172
58. Nishimura R.A., Edwards W.D., Warnes C.A., Reeder G.S., Holmes Jr. D.R., Tajik A.J., et al. Intravascular ultrasound imaging; in vitro validation and pathologic correlation. J Am Coll Cardiol 16 (1990) 145-154
59. Lefkovits J., Blankenship J.C., Anderson K.M., Stoner G.L., Talley J.D., Worley S.J., et al. Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial: evaluation of c7E3 for the prevention of ischemic complications. J Am Coll Cardiol 28 (1996) 849-855
60. Stankovic G., Chieffo A., Iakovou I., Orlic D., Corvaja N., Sangiorgi G., et al. Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents. Am J Cardiol 93 (2004) 1397-1401